Home
Home
/
Products
Products
/
Bioactive Compounds
Bioactive Compounds
/
Cell Cycle
Cell Cycle
/
Nucleoside Antimetabolites
Nucleoside Antimetabolites
Nucleoside Antimetabolites
Products (50)
N-(9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)-2-phenoxyacetamide
CAS No.:
119824-65-6
3′-Deoxy-3′-fluorouridine
CAS No.:
57944-13-5
5-Azidomethyl-2'-deoxyuridine
CAS No.:
59090-48-1
8-Hydroxyguanosine
CAS No.:
3868-31-3
8-Allylthioguanosine
CAS No.:
126092-30-6
Pyrene phosphoramidite dU
CAS No.:
199920-17-7
DMTr-LNA-C(Bz)-3-CED-phosphoramidite
CAS No.:
206055-78-9
3'-O-MOE-A(Bz)-2'-CED-phosphoramidite
CAS No.:
256224-01-8
(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-2-(hydroxymethyl)-2-methyltetrahydrofuran-3,4-diol
CAS No.:
152540-76-6
5-Hydroxymethylcytidine
CAS No.:
19235-17-7
9,9'-[(2r,3r,3as,5s,7ar,9r,10r,10as,12s,14ar)-3,5,10,12-Tetrahydroxy-5,12-Dioxidooctahydro-2h,7h-Difuro[3,2-D:3',2'-J][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-Diyl]bis(2-Amino-1,9-Dihydro-6h-Purin-6-One)
CAS No.:
61093-23-0
3'-Azido-3'-deoxy-5-fluorocytidine
CAS No.:
2095417-18-6
(2R,3R,4R,5R)-5-(2-amino-6-chloro-9H-purin-9-yl)-2-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol
CAS No.:
194034-59-8
2’-Azido-2’-deoxycytidine
CAS No.:
51034-68-5
3'-Azido-3'-deoxyadenosine
CAS No.:
58699-62-0
5-Carboxymethylaminomethyluridine
CAS No.:
69181-26-6
3’-Deoxy-3’-α-C-methyl-5-fluorouridine
CAS No.:
37731-67-2
2′,3′-Di-O-acetylguanosine
CAS No.:
42167-65-7
1-(2-Deoxy-β-D-erythro-pentofuranosyl)-4(1H)-pyrimidinone
CAS No.:
37109-98-1
7-(3-Deoxy-β-D-erythro-pentofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS No.:
40725-89-1
<
1
2
>
Products
CDMO Compounds
API & Candidates
Services
CDMO & Manufacturing
Custom Synthesis
Process Development
Lab To Pilot
Commercialization
Generic APIs
CRO
Preclinical
Pharmacology & Efficacy
DMPK & Bioanalysis
Toxicology & Safety
Disease Models
Technologies
High-Potent
Chiral Synthesis
Cloud Synthesis
Fermentation
Flow Chemistry
Biocatalysis
Support
Regulatory Support
Supply Chain Solutions
About
Perspectives
Contact